CI
The Cigna Group276.11
-1.04-0.38%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Key Stats
Market Cap
73.76BP/E (TTM)
12.22Basic EPS (TTM)
22.59Dividend Yield
0.02%Recent Filings
8-K
Board restructures committees
The Cigna Group's Board approved committee structure changes effective January 1, 2026, dissolving the Compliance Committee after March 2025 divestitures of Medicare and CareAllies businesses. Audit Committee becomes Audit and Compliance; Finance Committee gains technology oversight as Finance and Technology. Board takes direct clinical compliance reins. Streamlines governance amid health services shifts.
8-K
Strong Q3 revenues, outlook intact
The Cigna Group posted Q3 2025 revenues up 10% to $69.7 billion, with adjusted income from operations steady at $2.1 billion or $7.83 per share despite Cigna Healthcare's 12% drop from the HCSC Medicare divestiture. Evernorth surged 15% in revenues on pharmacy and specialty growth. Reaffirms 2025 adjusted EPS outlook at least $29.60. New rebate-free pharmacy model targets lower costs.
10-Q
Q3 FY2025 results
The Cigna Group posted Q3 revenues of $69.7B, up 10% y/y, driven by 16% pharmacy revenue growth to $56.1B while premiums fell 21% post-Medicare divestiture to HCSC (closed March 2025 for $4.9B cash consideration). Operating income held flat at $2.6B, but diluted EPS leaped to $6.98 from $2.63 on absent prior-year investment losses; reconciles to 267.5M shares. Cash dipped to $6.0B with $3.5B total debt (new $4.5B notes issued September 2025); operating cash YTD $3.5B. Evernorth powered gains. Yet price competition pressures margins.
8-K
Cigna closes $4.5B notes
The Cigna Group completed a $4.5 billion senior notes offering on September 4, 2025, issuing $1B 4.5% notes due 2030, $1.25B 4.875% due 2032, $1.5B 5.25% due 2036, and $750M 6% due 2056. Proceeds repay $2.0 billion term loan from August 5 funding a strategic investment, with remainder for general corporate purposes. Debt refinances at lower rates.
IPO
Employees
Sector
Industry
CLOV
Clover Health Investments, Corp
2.64+0.02
CNC
Centene Corporation
38.97-1.48
CNO
CNO Financial Group, Inc.
42.88+0.01
COR
Cencora, Inc.
341.72-8.60
CVS
CVS Health Corporation
78.29-1.40
EG
Everest Group, Ltd.
327.35-1.26
ELV
Elevance Health, Inc.
351.90-8.77
HUM
Humana Inc.
258.16-16.58
UNH
UnitedHealth Group Incorporated
334.20-6.90
UNM
Unum Group
77.52+0.41